A number of U.S. representatives on both sides of the aisle recently cosponsored a proposed bill, limiting the U.S. Food & Drug Administration’s (FDA’s) ability to regulate premium cigars. Although the House has yet to publish the text of the proposed bill, a similar bill proposed in the Senate on February 24 would prevent
